CAVALLARO, Lucas Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.553
AS - Asia 1.147
EU - Europa 932
SA - Sud America 154
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 3.862
Nazione #
US - Stati Uniti d'America 1.511
SG - Singapore 493
CN - Cina 395
DE - Germania 203
SE - Svezia 197
IE - Irlanda 187
BR - Brasile 119
IT - Italia 87
FI - Finlandia 85
HK - Hong Kong 72
VN - Vietnam 65
NL - Olanda 38
ZA - Sudafrica 37
TR - Turchia 35
GB - Regno Unito 28
IN - India 28
CA - Canada 26
RU - Federazione Russa 23
CI - Costa d'Avorio 21
FR - Francia 18
AR - Argentina 17
BD - Bangladesh 13
MX - Messico 13
IR - Iran 12
PL - Polonia 12
BE - Belgio 11
EC - Ecuador 8
ES - Italia 8
LT - Lituania 8
CZ - Repubblica Ceca 7
EU - Europa 6
AT - Austria 4
HU - Ungheria 4
ID - Indonesia 4
IQ - Iraq 4
UZ - Uzbekistan 4
IL - Israele 3
JP - Giappone 3
KG - Kirghizistan 3
MA - Marocco 3
RO - Romania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CO - Colombia 2
HR - Croazia 2
LV - Lettonia 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
UY - Uruguay 1
Totale 3.862
Città #
Chandler 307
Ashburn 271
Singapore 252
Dublin 175
Munich 164
Santa Clara 133
Beijing 81
Hong Kong 72
Boardman 63
Helsinki 62
Nanjing 60
Dearborn 55
Shanghai 53
Dallas 45
Los Angeles 45
New York 40
Johannesburg 34
Princeton 30
Izmir 28
Ho Chi Minh City 27
Ann Arbor 23
Abidjan 21
Turku 21
Buffalo 20
Parma 18
Frankfurt am Main 17
Wilmington 17
Moscow 15
Hefei 14
Pune 14
San Mateo 14
Nanchang 13
Shenyang 13
São Paulo 13
Tianjin 13
Changsha 11
London 11
Toronto 11
Brussels 10
Hanoi 10
Boston 9
Kunming 9
Jiaxing 8
Jinan 8
Warsaw 8
Columbus 7
Montreal 7
Norwalk 7
Bremen 6
Denver 6
Hangzhou 6
Houston 6
Kocaeli 6
Phoenix 6
Chengdu 5
Chennai 5
Curitiba 5
Guangzhou 5
Hebei 5
Menlo Park 5
Orem 5
Seattle 5
Zanjan 5
Brooklyn 4
Cambridge 4
Haiphong 4
Hải Dương 4
Mexico City 4
Milan 4
Ningbo 4
Nuremberg 4
Olomouc 4
Quito 4
Thái Bình 4
Thái Nguyên 4
Andover 3
Atlanta 3
Augusta 3
Bishkek 3
Brno 3
Chicago 3
Erbil 3
Frattamaggiore 3
Grafing 3
Marseille 3
Mumbai 3
Ottawa 3
Poplar 3
Rio Saliceto 3
Rome 3
Rostov-on-Don 3
Sacramento 3
San Jose 3
Timisoara 3
Tokyo 3
Udine 3
Amsterdam 2
Bauru 2
Biên Hòa 2
Bologna 2
Totale 2.559
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 257
Changes in surgical behaviors during the CoviD-19 pandemic. The SICE CLOUD19 Study 198
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 145
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 145
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 139
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 128
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 127
Serum pepsinogen II for early assessment of success of H. pylori eradication 127
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 121
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 120
Does chronic hypercalcemia influence serum pepsinogens levels? 119
Gastro panel® for detection of atrophic gastritis: The “Parma model” 118
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 118
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 117
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 116
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 116
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 115
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 115
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 113
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 113
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 112
PA.27 GASTRO PANEL® FOR DETECTION OF ATROPHIC GASTRITIS: THE “PARMA MODEL” 111
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 110
NOD2 and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired 105
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study 103
A new curcumin-based one week therapy for eradication of H. pylori infection 101
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 100
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 99
Cancro gastrico e Helicobacter pylori 98
Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study 94
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 92
La diagnosi sierologica delle gastriti croniche atrofiche 86
null 30
Totale 3.908
Categoria #
all - tutte 14.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 3 30 8 4
2021/2022244 7 11 1 44 29 6 12 11 10 15 32 66
2022/2023808 67 99 71 86 56 100 5 64 223 4 31 2
2023/2024279 11 19 5 6 21 68 23 32 10 17 36 31
2024/20251.087 37 39 43 58 126 132 59 63 179 70 92 189
2025/20261.063 231 119 154 209 279 71 0 0 0 0 0 0
Totale 3.908